nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Respiratory failure—Methotrexate—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Baclofen—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Baclofen—Urethral disorder—Vincristine—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Baclofen—Eye disorder—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Baclofen—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Baclofen—Flushing—Carmustine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Baclofen—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Baclofen—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Baclofen—Vaginal inflammation—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Baclofen—Anaemia—Bleomycin—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Baclofen—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Baclofen—Asthenia—Teniposide—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Baclofen—Malaise—Bleomycin—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Baclofen—Pruritus—Teniposide—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Baclofen—Arrhythmia—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Baclofen—Cardiac disorder—Vincristine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Baclofen—Alopecia—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Baclofen—Body temperature increased—Fludarabine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Baclofen—Mental disorder—Carmustine—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Baclofen—Vaginal infection—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Baclofen—Malnutrition—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Baclofen—Angiopathy—Vincristine—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Baclofen—Diarrhoea—Teniposide—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Baclofen—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Baclofen—Chest pain—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Baclofen—Myalgia—Bleomycin—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Baclofen—Alopecia—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Baclofen—Coma—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Baclofen—Back pain—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Baclofen—Discomfort—Bleomycin—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Baclofen—Mental disorder—Vincristine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Baclofen—Chills—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Baclofen—Bladder pain—Methotrexate—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Baclofen—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Baclofen—Alopecia—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Baclofen—Confusional state—Bleomycin—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Baclofen—Vision blurred—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Baclofen—Tremor—Carmustine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Baclofen—Oedema—Bleomycin—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Baclofen—Infection—Bleomycin—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Baclofen—Anaemia—Carmustine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Baclofen—Back pain—Vincristine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Baclofen—Vomiting—Teniposide—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Baclofen—Sepsis—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Baclofen—Agitation—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Baclofen—Asthenia—Fludarabine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Baclofen—Rash—Teniposide—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Baclofen—Dermatitis—Teniposide—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Baclofen—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Baclofen—Headache—Teniposide—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Baclofen—Pruritus—Fludarabine—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Baclofen—Back pain—Mitoxantrone—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Baclofen—Anorexia—Bleomycin—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Baclofen—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Baclofen—Anaemia—Vincristine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Baclofen—Agitation—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Baclofen—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Baclofen—Hypotension—Bleomycin—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Baclofen—Diarrhoea—Fludarabine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Baclofen—Convulsion—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Baclofen—Hypertension—Carmustine—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Baclofen—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Baclofen—Nausea—Teniposide—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Baclofen—Anaemia—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Baclofen—Vertigo—Vincristine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Baclofen—Chest pain—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Baclofen—Myalgia—Carmustine—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Baclofen—Anxiety—Carmustine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Baclofen—Paraesthesia—Bleomycin—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Baclofen—Malaise—Mitoxantrone—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Baclofen—Dyspnoea—Bleomycin—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Baclofen—Convulsion—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Baclofen—Hypertension—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Baclofen—Confusional state—Carmustine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Baclofen—Oedema—Carmustine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Baclofen—Decreased appetite—Bleomycin—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Baclofen—Myalgia—Vincristine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Baclofen—Visual disturbance—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Baclofen—Infection—Carmustine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Baclofen—Vomiting—Fludarabine—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Baclofen—Convulsion—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Baclofen—Rash—Fludarabine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Baclofen—Dermatitis—Fludarabine—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Baclofen—Hypertension—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Baclofen—Pain—Bleomycin—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Baclofen—Headache—Fludarabine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Baclofen—Tachycardia—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Baclofen—Myalgia—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Baclofen—Chest pain—Mitoxantrone—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Baclofen—Anxiety—Mitoxantrone—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Baclofen—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Baclofen—Lethargy—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Baclofen—Discomfort—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Baclofen—Oedema—Vincristine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Baclofen—Anorexia—Carmustine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Baclofen—Infection—Vincristine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Baclofen—Feeling abnormal—Bleomycin—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Baclofen—Osteoarthritis—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Baclofen—Confusional state—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Baclofen—Nervous system disorder—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Baclofen—Hypotension—Carmustine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Baclofen—Oedema—Mitoxantrone—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Baclofen—Nausea—Fludarabine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Baclofen—Infection—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Baclofen—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Baclofen—Shock—Mitoxantrone—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Baclofen—Urticaria—Bleomycin—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Baclofen—Anorexia—Vincristine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Baclofen—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Baclofen—Body temperature increased—Bleomycin—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Baclofen—Insomnia—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Baclofen—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Baclofen—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Baclofen—Paraesthesia—Carmustine—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Baclofen—Mood swings—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Baclofen—Hypotension—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Baclofen—Dyspnoea—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Baclofen—Somnolence—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Baclofen—Anorexia—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Baclofen—Ataxia—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Baclofen—Decreased appetite—Carmustine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Baclofen—Hypotension—Mitoxantrone—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Baclofen—Insomnia—Vincristine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Baclofen—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Baclofen—Paraesthesia—Vincristine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Baclofen—Constipation—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Baclofen—Pain—Carmustine—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Baclofen—Breast disorder—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Baclofen—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Baclofen—Decreased appetite—Vincristine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Baclofen—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Baclofen—Somnolence—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Baclofen—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Baclofen—Feeling abnormal—Carmustine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Baclofen—Fatigue—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Baclofen—Asthenia—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Baclofen—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Baclofen—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Baclofen—Pain—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Baclofen—Constipation—Vincristine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Baclofen—Pruritus—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Baclofen—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Baclofen—Fatigue—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Baclofen—Constipation—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Baclofen—Pain—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Baclofen—Abdominal pain—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Baclofen—Body temperature increased—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Baclofen—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Baclofen—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Baclofen—Dysuria—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Baclofen—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Baclofen—Body temperature increased—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Baclofen—Abdominal pain—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Baclofen—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Baclofen—Urticaria—Mitoxantrone—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Baclofen—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Baclofen—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Baclofen—Pneumonia—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Baclofen—Vomiting—Bleomycin—lymphatic system cancer	0.001	0.001	CcSEcCtD
Baclofen—Drowsiness—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Baclofen—Depression—Methotrexate—lymphatic system cancer	0.000998	0.000998	CcSEcCtD
Baclofen—Rash—Bleomycin—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Baclofen—Dermatitis—Bleomycin—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Baclofen—Asthenia—Carmustine—lymphatic system cancer	0.000989	0.000989	CcSEcCtD
Baclofen—Renal failure—Methotrexate—lymphatic system cancer	0.000984	0.000984	CcSEcCtD
Baclofen—Sweating—Methotrexate—lymphatic system cancer	0.00096	0.00096	CcSEcCtD
Baclofen—Haematuria—Methotrexate—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Baclofen—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Baclofen—Asthenia—Vincristine—lymphatic system cancer	0.000944	0.000944	CcSEcCtD
Baclofen—Diarrhoea—Carmustine—lymphatic system cancer	0.000943	0.000943	CcSEcCtD
Baclofen—Nausea—Bleomycin—lymphatic system cancer	0.000938	0.000938	CcSEcCtD
Baclofen—Asthenia—Mitoxantrone—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Baclofen—Dizziness—Carmustine—lymphatic system cancer	0.000911	0.000911	CcSEcCtD
Baclofen—Diarrhoea—Vincristine—lymphatic system cancer	0.0009	0.0009	CcSEcCtD
Baclofen—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Baclofen—Urethral disorder—Methotrexate—lymphatic system cancer	0.000881	0.000881	CcSEcCtD
Baclofen—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Baclofen—Vomiting—Carmustine—lymphatic system cancer	0.000876	0.000876	CcSEcCtD
Baclofen—Dizziness—Vincristine—lymphatic system cancer	0.00087	0.00087	CcSEcCtD
Baclofen—Rash—Carmustine—lymphatic system cancer	0.000869	0.000869	CcSEcCtD
Baclofen—Dermatitis—Carmustine—lymphatic system cancer	0.000868	0.000868	CcSEcCtD
Baclofen—Visual impairment—Methotrexate—lymphatic system cancer	0.000866	0.000866	CcSEcCtD
Baclofen—Headache—Carmustine—lymphatic system cancer	0.000863	0.000863	CcSEcCtD
Baclofen—Eye disorder—Methotrexate—lymphatic system cancer	0.00084	0.00084	CcSEcCtD
Baclofen—Tinnitus—Methotrexate—lymphatic system cancer	0.000838	0.000838	CcSEcCtD
Baclofen—Vomiting—Vincristine—lymphatic system cancer	0.000836	0.000836	CcSEcCtD
Baclofen—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000834	0.000834	CcSEcCtD
Baclofen—Rash—Vincristine—lymphatic system cancer	0.00083	0.00083	CcSEcCtD
Baclofen—Dermatitis—Vincristine—lymphatic system cancer	0.000829	0.000829	CcSEcCtD
Baclofen—Headache—Vincristine—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Baclofen—Nausea—Carmustine—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Baclofen—Angiopathy—Methotrexate—lymphatic system cancer	0.000815	0.000815	CcSEcCtD
Baclofen—Vomiting—Mitoxantrone—lymphatic system cancer	0.000815	0.000815	CcSEcCtD
Baclofen—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00081	0.00081	CcSEcCtD
Baclofen—Rash—Mitoxantrone—lymphatic system cancer	0.000808	0.000808	CcSEcCtD
Baclofen—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Baclofen—Chills—Methotrexate—lymphatic system cancer	0.000806	0.000806	CcSEcCtD
Baclofen—Headache—Mitoxantrone—lymphatic system cancer	0.000803	0.000803	CcSEcCtD
Baclofen—Alopecia—Methotrexate—lymphatic system cancer	0.000794	0.000794	CcSEcCtD
Baclofen—Mental disorder—Methotrexate—lymphatic system cancer	0.000787	0.000787	CcSEcCtD
Baclofen—Malnutrition—Methotrexate—lymphatic system cancer	0.000782	0.000782	CcSEcCtD
Baclofen—Nausea—Vincristine—lymphatic system cancer	0.000781	0.000781	CcSEcCtD
Baclofen—Dysgeusia—Methotrexate—lymphatic system cancer	0.000766	0.000766	CcSEcCtD
Baclofen—Nausea—Mitoxantrone—lymphatic system cancer	0.000761	0.000761	CcSEcCtD
Baclofen—Back pain—Methotrexate—lymphatic system cancer	0.000757	0.000757	CcSEcCtD
Baclofen—Vision blurred—Methotrexate—lymphatic system cancer	0.000737	0.000737	CcSEcCtD
Baclofen—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000726	0.000726	CcSEcCtD
Baclofen—Anaemia—Methotrexate—lymphatic system cancer	0.000723	0.000723	CcSEcCtD
Baclofen—Malaise—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Baclofen—Vertigo—Methotrexate—lymphatic system cancer	0.000703	0.000703	CcSEcCtD
Baclofen—Convulsion—Methotrexate—lymphatic system cancer	0.000678	0.000678	CcSEcCtD
Baclofen—Myalgia—Methotrexate—lymphatic system cancer	0.000666	0.000666	CcSEcCtD
Baclofen—Chest pain—Methotrexate—lymphatic system cancer	0.000666	0.000666	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000661	0.000661	CcSEcCtD
Baclofen—Discomfort—Methotrexate—lymphatic system cancer	0.000658	0.000658	CcSEcCtD
Baclofen—Confusional state—Methotrexate—lymphatic system cancer	0.000644	0.000644	CcSEcCtD
Baclofen—Infection—Methotrexate—lymphatic system cancer	0.000634	0.000634	CcSEcCtD
Baclofen—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000626	0.000626	CcSEcCtD
Baclofen—Skin disorder—Methotrexate—lymphatic system cancer	0.00062	0.00062	CcSEcCtD
Baclofen—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000617	0.000617	CcSEcCtD
Baclofen—Anorexia—Methotrexate—lymphatic system cancer	0.000608	0.000608	CcSEcCtD
Baclofen—Hypotension—Methotrexate—lymphatic system cancer	0.000596	0.000596	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000582	0.000582	CcSEcCtD
Baclofen—Insomnia—Methotrexate—lymphatic system cancer	0.000577	0.000577	CcSEcCtD
Baclofen—Paraesthesia—Methotrexate—lymphatic system cancer	0.000573	0.000573	CcSEcCtD
Baclofen—Dyspnoea—Methotrexate—lymphatic system cancer	0.000569	0.000569	CcSEcCtD
Baclofen—Somnolence—Methotrexate—lymphatic system cancer	0.000567	0.000567	CcSEcCtD
Baclofen—Dyspepsia—Methotrexate—lymphatic system cancer	0.000562	0.000562	CcSEcCtD
Baclofen—Decreased appetite—Methotrexate—lymphatic system cancer	0.000555	0.000555	CcSEcCtD
Baclofen—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000551	0.000551	CcSEcCtD
Baclofen—Fatigue—Methotrexate—lymphatic system cancer	0.00055	0.00055	CcSEcCtD
Baclofen—Pain—Methotrexate—lymphatic system cancer	0.000546	0.000546	CcSEcCtD
Baclofen—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000526	0.000526	CcSEcCtD
Baclofen—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000522	0.000522	CcSEcCtD
Baclofen—Urticaria—Methotrexate—lymphatic system cancer	0.000507	0.000507	CcSEcCtD
Baclofen—Abdominal pain—Methotrexate—lymphatic system cancer	0.000505	0.000505	CcSEcCtD
Baclofen—Body temperature increased—Methotrexate—lymphatic system cancer	0.000505	0.000505	CcSEcCtD
Baclofen—Asthenia—Methotrexate—lymphatic system cancer	0.000458	0.000458	CcSEcCtD
Baclofen—Pruritus—Methotrexate—lymphatic system cancer	0.000452	0.000452	CcSEcCtD
Baclofen—Diarrhoea—Methotrexate—lymphatic system cancer	0.000437	0.000437	CcSEcCtD
Baclofen—Dizziness—Methotrexate—lymphatic system cancer	0.000422	0.000422	CcSEcCtD
Baclofen—Vomiting—Methotrexate—lymphatic system cancer	0.000406	0.000406	CcSEcCtD
Baclofen—Rash—Methotrexate—lymphatic system cancer	0.000402	0.000402	CcSEcCtD
Baclofen—Dermatitis—Methotrexate—lymphatic system cancer	0.000402	0.000402	CcSEcCtD
Baclofen—Headache—Methotrexate—lymphatic system cancer	0.0004	0.0004	CcSEcCtD
Baclofen—Nausea—Methotrexate—lymphatic system cancer	0.000379	0.000379	CcSEcCtD
